Skip to main content
Edwards Lifesciences Logo

The ALLIANCE trial

ALLIANCE HCP AVIV
alliance inactive trial logo
alliance aviv active logo

One clinical program, multiple clinical trials

The ALLIANCE program consists of two clinical trials: The ALLIANCE trial (pivotal study) and the ALLIANCE aortic valve-in-valve (AViV) trial, each for a different patient condition.

About the ALLIANCE AViV trial

alliance trial logo

The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4S system in subjects who are at high or greater surgical risk with a failing aortic bioprosthetic valve.

Contact our Patient Support Center to find your nearest participating hospital.

Study device

The SAPIEN X4S system's adjustable valve sizing and commissural alignment are being studied in this trial. The SAPIEN X4S valve incorporates RESILIA tissue, which is created with a novel technology called Edwards Integrity Preservation.

sapien x4S

Edwards SAPIEN X4S Valve

Investigational Device

SAPIEN X4S valve sizing

Each valve size can be deployed to five or six distinct diameters, offering 16 total size options across three valves 
(0.5 mm increments)
SAPIEN X4S valve sizing
Adjustable sizing can allow for more than one valve size to be selected for a given annulus area
In a Failing THV
Adjustable sizing in failing THV chart

Index Valve Narrowest Diameter (mm); CT area derived in millimeters

In a failing surgical valve
Adjustable sizing in failing surgical valve chart

True Internal Diameter (ID) of Index Valve (mm)

Commissural alignment being studied

The SAPIEN X4S transcatheter heart valve system is designed with rotational alignment. It is being studied for its ability to align the THV commissures relative to the anatomy.

Rational alignment

Valve features

Valve features
  • number one image
    Cobalt chromium frame
    • Shared frame material designed for radial strength
    • Similar frame heights
  • number two image
    Bovine pericardial tissue
    • Both valves utilize RESILIA tissue which enables dry-storage and anti-calcification properties
    • SAPIEN X4S valve leaflet design allows for full function across deployment range
  • number three image
    Outer sealing skirt
    • Shared PET outer sealing skirt material
    • SAPIEN X4S valve skirt covers ~50% of the valve height
    • SAPIEN X4S valve skirt designed to function across deployment range
CAUTION: The SAPIEN X4S valve is an INVESTIGATIONAL DEVICE. Limited by Federal (US) law to investigational use only. Comparison shown is illustrative only and does not establish safety, effectiveness, or equivalence for the SAPIEN X4S valve. See Instructions for Use for approved uses of the commercial SAPIEN 3 Ultra RESILIA valve.

RESILIA tissue platform

RESILIA tissue platform

* Clinical data on surgical valves with RESILIA tissue up to 7-year follow-up have been published, with additional follow-up to 10-years in progress.1

RESILIA tissue is incorporated into the SAPIEN X4S valves under investigation.

The ALLIANCE Trial

Eligibility criteria

  • Failing aortic bioprosthetic valve demonstrating ≥ moderate stenosis and/or ≥ moderate insufficiency
  • Bioprosthetic valve size suitable for SAPIEN X4 valve
  • New York Heart Association functional class ≥ II
  • Heart Team agrees the subject is at high or greater surgical risk

The SAPIEN X4S system AVIV procedural animation

contact us lady

We’re here for you

We are committed to providing the highest levels of customer service to help our patients improve their quality of life. For any questions, please contact the Edwards Patient Support Center. 

For details about the trial, visit NCT05172973 at ClinicalTrials.gov.

Give us a call

888.713.1564

References

  1. Svensson L, Blackstone E, Bavaria J, et al. Long-term outcomes following aortic valve replacement with a novel tissue bioprosthesis: 10-year results from the COMMENCE trial. Abstract presented at: American Association for Thoracic Surgery (AATS) Annual Meeting; 2026.
CAUTION: Investigational device.

CAUTION: Investigational device. Limited by Federal (United States) law to investigational use.

PP--US-7744 v3.0